IAMGOLD Corporation headed into its Q1 2026 earnings release with the borrow market flashing an unusually sharp signal — even though short sellers were far from crowding the trade.
The most striking pre-earnings move was in cost to borrow, which more than doubled in the week before the print, climbing from roughly 0.78% to 1.60%. That is still a modest absolute rate, and with availability well above zero, the lending pool is not anywhere near tight. But the pace of the move — a 106% jump in seven days — pointed to a meaningful uptick in borrow demand on a stock where borrowing activity had been quiet for months. Short interest itself edged up about 20% over the past month to reach roughly 0.76% of the free float: low in absolute terms, but the trend is worth flagging. The ORTEX short score, at 27, places IMG in the 86th percentile of its sector — ranking high relative to gold peers even with a small headline figure.
The backdrop was a stock under pressure. IMG shed roughly 17% over the month heading into results, closing at CAD 22.16, while the gold-mining peer group was also weak — fell 11% on the week and dropped 10%. The sector-wide retreat meant IAMGOLD's drawdown was not idiosyncratic, but it did compress valuation multiples sharply: the P/E multiple contracted by about 1.6x over 30 days, and the P/B ratio dropped 0.32x, landing at roughly 1.5x book. The EV/EBITDA reading of 3.9x is lean for a mid-tier producer. On forward earnings momentum, IAMGOLD ranks in the 82nd percentile for year-on-year EPS growth expectations — a factor that cut against the bearish price action.
The institutional register is anchored by gold-specialist money. Van Eck Associates holds 7.8% of shares, with FMR (Fidelity US) adding a notable 10.9 million shares in the most recent quarter to reach a 5.6% stake. Sprott added roughly 1.1 million shares. On the insider side, CEO Renaud Adams sold C$1.9 million worth of stock in early March near CAD 31 — approximately 40% above the pre-results close. The trade carried a low significance score and may reflect routine plan activity, but the gap between that exit price and the current level adds context to how far the stock has moved in two months.
The Q1 print — adjusted EPS of $0.67 versus a $0.53 consensus estimate, with sales of $1.03 billion beating the $974 million forecast — delivered a clear beat on both lines. The earnings report has now answered whether production economics held up at elevated gold prices. What the market's subsequent reaction will test is whether the share price, already down sharply from insider-sale levels, has absorbed enough of the sector re-rating, or whether the operational beat is enough to reverse two months of multiple compression.
See the live data behind this article on ORTEX.
Open IMG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
